Unknown PHASE3 INTERVENTIONAL 4-arm NCT01587846

Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in Children

Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in Children - Randomized, Double Blind, Placebo Controlled Study

Sponsor: BioGaia AB

Conditions Abdominal Pain Constipation - Functional

Interventions Administration of L.reuteri in children with abdominal pain Administration of L.reuteri in children with constipation Administration of placebo in children with abdominal pain Administration of placebo in children with constipation

Updated 5 times since 2017 Last updated: Oct 2, 2012 Started: Oct 31, 2012 Primary completion: Jun 30, 2013 Completion: Oct 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Abdominal Pain and Constipation - Functional and is currently ongoing. BioGaia AB leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

BioGaia AB
Sisters of Mercy University Hospital

Data source: Sisters of Mercy University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zagreb, Croatia